Jignasa Savjani

Dr. Jignasa Savjani


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2021 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
KCKhushbu R. Chaudhari
Khushbu R. Chaudhari
JSJignasa Savjani
Jignasa Savjani
KSKetan T. Savjani
Ketan T. Savjani
HSHarsh Shah
Harsh Shah
Ritonavir is a BCS class II antiretroviral agent which shows poor aqueous solubility and low oral bioavailability. The cocrystallization approach was selected to overcome these problems and to improve the physicochemical and mechanical properties of Ritonavir. The novel pharmaceutical Ritonavir-L-tyrosine cocrystals (RTC at a molar ratio of 1:1) were synthesized using the liquid assisted grinding (LAG) method. The possibility of molecular interactions between drug and coformer were studied using Gold software version 5.2. The newly formed crystalline solid phase was characterized through Differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), Fourier transform-infrared spectroscopy (FT-IR), Scanning electron microscopy (SEM), and Solid-State Nuclear magnetic resonance (SSNMR). The improved pharmaceutical properties were confirmed by solubility, dissolution, and powder compaction study. The prepared cocrystals exhibited an 11.24-fold increase in solubility and a 3.73-fold increase in % of drug release at 1 h compared to pure drug. Tabletability and compaction behaviour of the pure drug and cocrystal with added excipients assessed. The tabletability profile of cocrystals showed enhanced tabletting performance as compared to pure drug. The stability studies revealed that cocrystals were stable for at least one month when stored at 40 °C/75% RH and 25 °C/60% RH conditions. The cocrystallization approach was found to be very promising and showed an overall improved performance of Ritonavir.

29 November 2022 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
DYDattatraya Yadav
Dattatraya Yadav
JSJignasa Savjani
Jignasa Savjani
KSKetan Savjani
Ketan Savjani
AKAakash Kumar
Aakash Kumar
SPSnehal Patel
Snehal Patel

1 April 2018 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
SSSurmil Shah
Surmil Shah
BPBhumika Patel
Bhumika Patel
JSJignasa Savjani
Jignasa Savjani

11 February 2023 in Journal of Pharmaceutical Innovation
Verified
Journal Article
Closed access
PDF file
DYDattatraya Yadav
Dattatraya Yadav
JSJignasa Savjani
Jignasa Savjani
KSKetan Savjani
Ketan Savjani
HSHarsh Shah
Harsh Shah